In October 2016, the owners of BioWorld – the Intellectual Property & Science business of Thomson Reuters – sold the business to Onex Corp. and Baring Private Equity Asia. The new company has since emerged as Clarivate Analytics, a name that speaks to accelerating the pace of innovation with the trusted insights and analytics it provides to customers.

With this change comes a fresh look for BioWorld, the news source of record covering the development of innovative human therapies. We will continue to cut through the clutter to deliver unbiased, critical news and analysis.

We're also rebranding BioWorld's companion news service, Medical Device Daily, to BioWorld MedTech. The branding change is part of an alignment of our news offerings and highlights the crossover trend we're seeing between medical technologies and drugs.

Contact News Director Lynn Yoffee with questions or comments. Lynn.Yoffee@Clarivate.com